Background: Epidural injections have been used
for pain relief since the 1880s. Corticosteroids are
antiinflammatory medications that can alleviate
pain, but also have harmful systemic adverse
effects. Literature regarding methylprednisolone
dosage efficacy is limited.
Objectives: To determine the lowest effective
dose of methylprednisolone in a lumbar epidural
steroid injection (LESI) for maximal pain relief
without exposing patients to adverse events
caused by steroid use.
Study Design: Retrospective chart review.
Setting: Outpatient interventional pain clinic at
an academic center.
Methods: Adults (n = 133), aged 18 to 85 years,
with low-back pain and radicular symptoms
treated with LESI from August 2011 to November
2015. Patients who received prior cervical
epidural steroid injections were excluded. Interventions
were
LESI with methylprednisolone 40 mg, 80 mg,
or 120 mg. Main outcome measures showed
change in pain score using a numeric pain scale
(NPS; 0 = no pain, 10 = excruciating pain), and
patient’s self-reported reduction in pain (percentage),
pre- and postprocedure. The primary endpoint
measurement was 2 weeks postinjection.
Adverse effects were recorded.
Results: The number of patients who received
each dose varied: n = 88 received 120 mg, n = 30
received 80 mg, and n = 13 received 40 mg. The
NPS pain scores pre- and postprocedure for 120
mg were 8.89 ± 1.32 and 4.08 ± 3.74, (mean ±
standard deviation), respectively; for 80 mg: 9.06
± 1.00 and 3.75 ± 4.00; and for 40 mg: 9.00 ±
1.00 and 4.00 ± 0.00. Percentage of pain relief for
120 mg, 80 mg, and 40 mg was 57.26%, 50.74%,
and 57.26, respectively (P = 0.3347). n = 4 experienced
adverse effects, all received 120 mg.
Conclusions: All 3 dosage groups had similar
efficacy in pain relief, but only patients who received
120 mg experienced adverse effects. This
demonstrates that lower dosages can be used for
pain relief with less potential harm to the patient.
Key words: Methylprednisolone, interlaminar
epidural, radiculopathy